Media Resources

Parsemus Foundation Press Information

About the Parsemus Foundation

The Parsemus Foundation works to create meaningful improvements in human and animal health and welfare by advancing innovative and neglected medical research. The foundation supports proof-of-concept studies and then seeks to raise awareness of results, to ensure that they change treatment practice rather than disappear into the scientific literature. Many of the studies the foundation supports involve low-cost approaches that are not under patent, and are thus unlikely to be pursued by pharmaceutical companies due to limited profit potential.

The Parsemus Foundation’s main focus has been developing Vasalgel as a non-hormonal male contraceptive. For information on Vasalgel, including publications, past press coverage, images, infographics and media resources, please see the Revolution Contraceptives website.

For information on the development of non-hormonal male contraceptives, visit the Male Contraceptive Initiative.

The foundation also works on pet contraception, including calcium chloride nonsurgical neuter and hormone-sparing sterilization options; noninvasive treatment for benign prostatic hyperplasia (enlarged prostate); and serves as a resource for information on over-used medical procedures, innovative breast cancer treatment, aldosterone and hearing, and the effect of testosterone and DHA on Alzheimer’s disease.

A major effort since 2020 has been addressing the need for research on COVID-19 treatments. The Parsemus Foundation has supported clinical studies on the effectiveness of existing medications to treat COVID infection, including enrollment support for the University of Minnesota’s COVID-Out trial.

For media coverage of our projects, please contact us at media@parsemusfoundation.org

Latest News

COVID-Out Clinical Trial 

The COVID-Out clinical trial is aimed at understanding if safe, commonly available medications may treat COVID-19 symptoms and those of long COVID. The study examines the medications metformin, ivermectin, and fluvoxamine, which are known to decrease inflammatory proteins (cytokines) in the body. They also appear to possibly stop the proteins inside cells that help viruses reproduce and spread. This randomized, controlled clinical trial was conducted by the University of Minnesota under the direction of Dr. Carolyn Bramante. 

The Role of the Parsemus Foundation

The Parsemus Foundation provided pilot funding to the University of Minnesota to initiate the COVID-Out study. Additional major funders include the University of Minnesota Clinical Translational Science Institute, the Rainwater Foundation, FastGrants, and UnitedHealth Group Research and Development.

Importantly, the Parsemus Foundation supported and coordinated enrollment advertising efforts for the trial. This included development of educational materials, oversight of online advertising, and initial screening of interested individuals. This work helped to increase enrollment and reach the target number of patients more quickly – so that results of this important trial could be reported and influence standards of COVID treatment.

Image Files, Videos, and Printable Materials

Parsemus Foundation Logo

Vector-based logo in full color

Vector-based logo in silhouette

Executive And Associate Headshots

Elaine Lissner, Founder and Trustee, Parsemus Foundation and Revolution Contraceptives, LLC

Linda Brent, PhD, MBA, Executive Director, Parsemus Foundation

Program: Contraception in Humans

Vasalgel Logo

Vasalgel wordmark, Vasalgel tagline, and Revolution Contraceptives logo (Printable artwork)

Current Options in Male Contraception

Infographic by Revolution Contraceptives, data from United Nations World Contraceptive Patterns 2015

Existing Methods by MCI

Existing Contraceptive Methods

Infographic by Male Contraceptive Initiative

Male Contraceptive Research Locations

Infographic by Male Contraceptive Initiative

Contraceptive Use by Method

2019 Report by United Nations Dept. of Economic and Social Affairs

Program: Sterilization in Animals

Infographic about the health risks to dogs of traditional spay and neuter

The Risks of Spay & Neuter

Infographic about the health risks to dogs of gonadectomy

Golden retriever among yellow flowers

Overview of Hormone-Sparing Sterilization

Printable handout by Parsemus Foundation

Alternatives in Sterilization and Contraception in Dogs

Video presentation by Dr. Michelle Kutzler, 2021

Photo of dog from the study

Calcium Chloride Nonsurgical Neuter: Bibliography

Reference resource by Parsemus Foundation

Hormone-sparing Spay Advertising

Printable ad (with crop marks) by Parsemus Foundation

Hormone-sparing Sterilization Advertising

Printable ad (with crop marks) by Parsemus Foundation

Program: Animal Welfare

Zebrafish in lush green aquarium

Aqualabyrinth - A New Enrichment for Laboratory Zebrafish

White Paper by Dorothée Therrien and Aurore Dodelet-Devillers

We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today